Gansu Provincial Hospital

Futó vizsgálatok

• Toboroz

  Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre

  NCT07687186· 3. fázis· Tasly Pharmaceutical Group Co., Ltd· Forrás

• Még nem toboroz

  The Correlation of Postoperative Polyp Recurrence and Colorectal Cancer

  NCT07708415· Gansu Provincial Hospital· Forrás

• Toboroz

  A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.

  NCT07593027· 1/2. fázis· ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.· Forrás

• Toboroz

  Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.

  NCT07385703· 3. fázis· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Forrás

• Toboroz

  Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

  NCT07464587· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás

• Toboroz

  To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus

  NCT07447986· 2. fázis· Hangzhou Sumgen Biotech Co., Ltd.· Forrás

• Toboroz

  A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  NCT07369011· 3. fázis· Eli Lilly and Company· Forrás

• Fut, nem toboroz

  A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)

  NCT07230119· 3. fázis· Beijing QL Biopharmaceutical Co.,Ltd· Forrás

• Toboroz

  Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2

  NCT07263308· 3. fázis· Capital Medical University· Forrás

• Még nem toboroz

  Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma

  NCT07187960· 3. fázis· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Forrás

• Fut, nem toboroz

  A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

  NCT07245407· AstraZeneca· Forrás

• Toboroz

  A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

  NCT07202884· 3. fázis· Eli Lilly and Company· Forrás

• Még nem toboroz

  Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

  NCT07147946· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás

• Toboroz

  Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

  NCT06949033· 3. fázis· Zuoyi Jiao· Forrás

• Toboroz

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06935357· 3. fázis· Biogen· Forrás

• Toboroz

  Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

  NCT06925243· 3. fázis· Zuoyi Jiao· Forrás

• Toboroz

  TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

  NCT06829784· 3. fázis· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Forrás

• Toboroz

  A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors（G-MAP 101）

  NCT06796699· 1. fázis· Suzhou Genhouse Bio Co., Ltd.· Forrás

• Toboroz

  A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

  NCT06532006· 3. fázis· Shanghai Henlius Biotech· Forrás

• Fut, nem toboroz

  A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast Cancer

  NCT06561607· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás

• Fut, nem toboroz

  SIM0718 Treatment of Asthma Clinical Study

  NCT06488755· 3. fázis· Simcere Pharmaceutical Co., Ltd· Forrás

• Toboroz

  Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  NCT05696626· 3. fázis· LeonaBio· Forrás

• Fut, nem toboroz

  Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

  NCT06577792· Sun Yat-sen University· Forrás

• Toboroz

  Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

  NCT05866029· Peking Union Medical College Hospital· Forrás

• Toboroz

  Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

  NCT05862337· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás

• Fut, nem toboroz

  A Study of Telitacicept for IgA Nephropathy (TELIGAN)

  NCT05799287· 3. fázis· RemeGen Co., Ltd.· Forrás

• Még nem toboroz

  Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

  NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Forrás

• Fut, nem toboroz

  Newly Diagnosed Glioblastoma

  NCT04959500· 2. fázis· Sun Yat-sen University· Forrás

• Fut, nem toboroz

  A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer

  NCT04854668· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás

• Fut, nem toboroz

  Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)

  NCT06524427· Sun Yat-sen University· Forrás

• Fut, nem toboroz

  A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

  NCT04344158· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyomor- és nyelőcsőrák4 toboroz
• Elhízás2 toboroz
• Koszorúér-betegség2 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)2 toboroz
• Asztma1 toboroz
• Áttétes emlőrák1 toboroz
• Csontritkulás1 toboroz
• Follikuláris limfóma1 toboroz
• Gyermekkori daganatok1 toboroz
• IgA-nefropátia1 toboroz
• Lupus (SLE)1 toboroz
• Magas vérnyomás1 toboroz
• Máj- és epeúti rák1 toboroz
• Obstructive sleep apnoea1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Stroke (szélütés)1 toboroz
• Szívelégtelenség1 toboroz
• Vastagbélrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  Efficacy and Safety of CP006 Inhalation Powder in Participants With Asthma

  NCT07807007· 2. fázis· Shanghai Xin Huanghe Pharmaceutical Co., Ltd.· Forrás

• Lezárult

  A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects

  NCT06738979· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás

• Lezárult

  A Clinical Study of JS005 in Patients With Ankylosing Spondylitis

  NCT06250062· 2. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás

• Lezárult

  A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer

  NCT06029127· 2. fázis· BeiGene· Forrás

• Lezárult

  A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA)

  NCT06103825· 3. fázis· Ignis Therapeutics (Suzhou) Limited· Forrás

• Lezárult

  Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale

  NCT05546320· 2. fázis· Chinese Academy of Medical Sciences, Fuwai Hospital· Forrás

• Leállították

  A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

  NCT05292196· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás

• Lezárult

  A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer

  NCT04574284· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Gyomor- és nyelőcsőrák42 munka · 4 vizsgálat
• Aplastic anaemia3 munka · 0 vizsgálat